ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,718,713 | -3.8% | 63,964 | +27.7% | 0.01% | +8.3% |
| Q2 2023 | $1,786,031 | -19.0% | 50,085 | -7.9% | 0.01% | -7.7% |
| Q4 2022 | $2,205,815 | +189.5% | 54,384 | +135.8% | 0.01% | +225.0% |
| Q3 2022 | $762,000 | -62.3% | 23,063 | -59.8% | 0.00% | -66.7% |
| Q2 2022 | $2,020,000 | -60.5% | 57,380 | -48.4% | 0.01% | -72.1% |
| Q1 2022 | $5,119,000 | +212.5% | 111,303 | +350.5% | 0.04% | +168.8% |
| Q4 2021 | $1,638,000 | +304.4% | 24,709 | +280.8% | 0.02% | +220.0% |
| Q3 2021 | $405,000 | -92.3% | 6,489 | -89.8% | 0.01% | -91.5% |
| Q2 2021 | $5,276,000 | +98.4% | 63,703 | +58.9% | 0.06% | +73.5% |
| Q1 2021 | $2,659,000 | +522.7% | 40,092 | +619.7% | 0.03% | +466.7% |
| Q4 2020 | $427,000 | -22.5% | 5,571 | -56.5% | 0.01% | -25.0% |
| Q3 2020 | $551,000 | +56.5% | 12,806 | +57.1% | 0.01% | +33.3% |
| Q2 2020 | $352,000 | -32.4% | 8,154 | -55.0% | 0.01% | -57.1% |
| Q1 2020 | $521,000 | -80.4% | 18,118 | -56.7% | 0.01% | -71.4% |
| Q4 2019 | $2,654,000 | +182.6% | 41,849 | +25.7% | 0.05% | +157.9% |
| Q3 2019 | $939,000 | -26.3% | 33,306 | -30.7% | 0.02% | -17.4% |
| Q2 2019 | $1,274,000 | +359.9% | 48,062 | +218.2% | 0.02% | +155.6% |
| Q1 2019 | $277,000 | +15.4% | 15,104 | -21.7% | 0.01% | -18.2% |
| Q4 2018 | $240,000 | -1.6% | 19,289 | +7.5% | 0.01% | -8.3% |
| Q2 2018 | $244,000 | +771.4% | 17,941 | +365.6% | 0.01% | +500.0% |
| Q3 2016 | $28,000 | +3.7% | 3,853 | -23.3% | 0.00% | 0.0% |
| Q2 2016 | $27,000 | – | 5,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |